Valiant Laboratories Limited is an India-based pharmaceutical ingredient manufacturing company. The Company is focused on manufacturing a Paracetamol active pharmaceutical ingredient (API)/bulk drug. It has several applications in the treatment of conditions such as headache, muscle ache, arthritis, backache, toothache, cold and fever. It is also used in the management of severe pain such as post-surgical and cancer pain. It operates a single-location manufacturing facility on the Tarapur industrial estate.

Employees

Sector

Specialty Chemicals

More about the company

Quotes

Date	Price	Change	Volume
26-06-25	₹68.00	-0.06%	8,652
26-06-24	₹68.04	-0.09%	3,770
26-06-23	₹68.10	+1.14%	17,303
26-06-22	₹67.33	-0.84%	22,613
26-06-19	₹67.90	-1.21%	6,766

End-of-day quote NSE India S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote NSE India S.E. Other stock markets 2026-06-25			5-day change	1st Jan Change
68.00 ^INR	-0.06%		+2.06%	-2.86%

05-20	Valiant Organics Limited agreed to acquire 34.26% stake in Valiant Laboratories Limited from Dhanvallabh Ventures LLP.	CI
05-14	Valiant Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Market Cap	2.8B 29.71M 26.1M 24.05M 22.48M 42.17M 42.94M 289M 112M 1.38B 112M 109M 4.8B	P/E 2024	1,725x	P/E 2025	-150x
Enterprise Value	3.26B 34.51M 30.31M 27.93M 26.12M 48.98M 49.88M 335M 130M 1.61B 130M 127M 5.58B	EV / Sales 2024	3.09x	EV / Sales 2025	2.83x
Free-Float	23.77%	Yield 2024 *	-	Yield 2025	-

05-20	Valiant Organics Limited agreed to acquire 34.26% stake in Valiant Laboratories Limited from Dhanvallabh Ventures LLP.	CI
05-14	Valiant Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
04-23	Valiant Laboratories Limited Announces Resignation of Bhanudas D. Patil as Q.C Manager, Senior Management Personnel, Effective April 22, 2026	CI
02-11	Valiant Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
01-15	Valiant Laboratories Ltd receives notice for total tax demand of approx. 125.3 million rupees	RE
11-11	Valiant Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
11-07	Valiant Laboratories Arm Begins Commercial Operations at New Unit in Gujarat, India; Shares Up 4%	MT
25-09-25	Valiant Laboratories Limited Approves Change in Designation of Paresh Shah from Executive Director to Whole-Time Director, Effective September 25, 2025	CI
25-08-08	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-07-16	Valiant Laboratories Gets Board Nod for INR815 Million Rights Issue; Shares Up 4%	MT
25-07-15	Valiant Laboratories says rights issue price set at 75 rupees per share, entitlement ratio 1:4	RE
25-07-09	Valiant Laboratories approves rights issue up to 814.7 mln rupees	RE
25-07-09	Valiant Laboratories Gets Board Nod to Raise Up To INR815 Million Through Rights Issue	MT

1 day	-0.06%
1 week	+2.06%
Current month	-12.19%
1 month	-11.55%
3 months	+14.34%
6 months	-9.31%
Current year	-2.86%

Valiant Laboratories Limited Stock

Stocks

VALIANTLAB

INE0JWS01017

Specialty Chemicals

Valuation: Valiant Laboratories Limited

Chart: Valiant Laboratories Limited

Latest news : Valiant Laboratories Limited

Quotes and Performance

Course Extremes

Managers and Directors: Valiant Laboratories Limited

Other Specialty Chemicals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	66.16	70.35
1 month	64.6	81.9
Current year	49.51	83.7
1 year	49.51	123.88
3 years	49.51	214.95
5 years	49.51	214.95
10 years	49.51	214.95

Manager	Title	Age	Since
Santosh Vora CEO	Chief Executive Officer	31	2021-08-20
Paresh Shah DFI	Director of Finance/CFO	66	2021-08-15
Akshay Dnyaneshwar Gangurde CMP	Compliance Officer	-	2025-07-08

Director	Title	Age	Since
Santosh Vora BRD	Director/Board Member	31	2021-08-20
Sonal Amit Vira BRD	Director/Board Member	43	2022-02-15
Paresh Shah BRD	Director/Board Member	66	2021-08-15

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VALIANT LABORATORIES LIMITED	-0.06%	+2.06%	-40.69%	-	39.21M
ECOLAB INC.	+1.78%	+4.51%	+5.38%	+57.84%	77.76B
GIVAUDAN SA	-0.91%	+6.80%	-14.99%	+14.67%	38.9B
SIKA AG	+1.97%	+4.48%	-23.67%	-30.15%	32.55B
FUJIFILM HOLDINGS CORPORATION	+2.40%	+1.07%	+11.39%	+20.64%	24.63B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-3.27%	-11.91%	+115.35%	+4.97%	21.59B
EMS-CHEMIE HOLDING AG	+0.57%	+1.28%	+19.68%	+6.43%	20.38B
DUPONT DE NEMOURS, INC.	-0.01%	-4.21%	-32.66%	-32.23%	18.61B
ALBEMARLE CORPORATION	-4.59%	-15.32%	+134.38%	-35.94%	17.44B
SYMRISE AG	-0.96%	+5.59%	-8.62%	-5.33%	13.97B
Average	-0.31%	-0.43%	+16.56%	+0.10%	26.59B
Weighted average by Cap.	+0.28%	+0.83%	+14.48%	+13.29%

	2024	2025
Net sales	1.82B 19.29M 16.95M 15.61M 14.6M 27.38M 27.89M 187M 72.57M 897M 72.45M 70.87M 3.12B	1.33B 14.14M 12.42M 11.44M 10.7M 20.06M 20.43M 137M 53.16M 657M 53.08M 51.92M 2.28B
Net income	3.2M 33.87K 29.75K 27.41K 25.63K 48.07K 48.95K 329K 127K 1.58M 127K 124K 5.47M	-22.01M -233K -205K -189K -177K -331K -337K -2.27M -877K -10.85M -876K -857K -37.71M
Net Debt	-671M -7.11M -6.25M -5.76M -5.38M -10.09M -10.28M -69.06M -26.75M -331M -26.71M -26.12M -1.15B	453M 4.8M 4.22M 3.88M 3.63M 6.81M 6.94M 46.61M 18.05M 223M 18.02M 17.63M 776M